SCHEMBL20206540

SCHEMBL20206540

CC(C)(C)CNC(=O)c1cccc(C(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.55
HDAC8 Q9BY41 3/20 0.54
HDAC6 Q9UBN7 2/20 0.54
NR1H4 Q96RI1 2/20 0.53
ALDH1A1 P00352 1/20 0.52
POLB P06746 1/20 0.52
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
RAB9A P51151 2/20 0.51
TP53BP1 Q12888 1/20 0.50
CTSL P07711 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
ESRRG P62508 1/20 0.47
GAA P10253 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HDAC3 O15379 1/20 0.46
LMNA P02545 1/20 0.45
PRSS1 P07477 1/20 0.45
CTSG P08311 1/20 0.45
CTRB1 P17538 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21652173 0.88 ACHE (0.60) ACHEHDAC8HDAC6NR1H4ALDH1A1
SCHEMBL13155121 0.85 ALDH1A1 (0.57) ACHEHDAC8HDAC6NR1H4ALDH1A1
SCHEMBL12201910 0.83 POLB (0.58) ACHEHDAC8HDAC6NR1H4ALDH1A1
SCHEMBL21020967 0.82 HDAC8 (0.59) HDAC8HDAC6POLBKMT2AMEN1
SCHEMBL3655101 0.82 KDM4E (0.59) ALDH1A1POLBKMT2AMEN1RAB9A
SCHEMBL13698098 0.81 ACHE (0.60) ACHEHDAC8HDAC6NR1H4ALDH1A1
SCHEMBL23191205 0.81 ALDH1A1 (0.57) ACHEHDAC8HDAC6NR1H4ALDH1A1
SCHEMBL21652313 0.81 CTSL (0.66) ACHEHDAC8HDAC6NR1H4ALDH1A1
SCHEMBL13501434 0.81 ACHE (0.53) ACHEHDAC8HDAC6NR1H4ALDH1A1
SCHEMBL10203242 0.81 GAA (0.73) ACHEHDAC8HDAC6NR1H4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10682419-B2 Prodrugs of peptide epoxy ketone protease inhibitors ONYX THERAPEUTICS, INC. (US) 2020-06-16 US disclosed
US-20180147291-A1 PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS ONYX THERAPEUTICS, INC. 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180147291-A1 PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS PREP, VIP, PEPD ACHE 1693/4885HDAC8 1018/4885HDAC6 2753/4885
US-10682419-B2 Prodrugs of peptide epoxy ketone protease inhibitors PREP, VIP, PEPD ACHE 1693/4885HDAC8 1018/4885HDAC6 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.